Ozempic Lawsuit Canada — Were You Seriously Harmed?
Canadians who experienced gastroparesis, bowel obstruction, or vision loss after taking Ozempic may qualify for a free legal case review. Get answers today.
- Free, no-obligation case review
- No fees unless your case settles
- All Canadian provinces and territories
Speak with a specialist
1-800-000-0002
Mon–Fri 8am–8pm ET
Free & confidential
13
Provinces & territories served
100%
Free case review
0
Upfront fees
Free Case Review — No Obligation
Do You Qualify?
Answer 3 quick steps to find out.
Step 1 of 3
What Is Ozempic and Why Are People Filing Claims?
Ozempic (semaglutide) is a GLP-1 receptor agonist originally approved by Health Canada for the management of type 2 diabetes in adults. It works by mimicking the GLP-1 hormone, which slows stomach emptying and reduces appetite. In recent years, it has been widely prescribed off-label for weight loss.
While Ozempic has been effective for many patients, a significant number of users in Canada and elsewhere have reported serious gastrointestinal complications — including gastroparesis (delayed gastric emptying), bowel obstruction, and severe nausea requiring hospitalization. Emerging reports have also linked GLP-1 medications to non-arteritic anterior ischemic optic neuropathy (NAION), a cause of permanent vision loss.
Legal proceedings are underway in Canada and the United States, with individuals alleging that Novo Nordisk, the manufacturer of Ozempic, failed to adequately warn prescribers and patients about these risks. Canadian cases are in varying stages of development and eligibility requirements apply.
Ozempic Side Effects That May Qualify
These are the most commonly reported serious side effects in current Ozempic legal inquiries. If you experienced one or more of these after taking Ozempic, you may qualify.
Gastroparesis
A condition where the stomach cannot empty itself normally, causing nausea, vomiting, bloating, and severe abdominal pain. GLP-1 medications slow gastric motility and have been linked to gastroparesis.
Stomach Paralysis
Closely related to gastroparesis, stomach paralysis refers to the stomach's inability to contract and move food into the small intestine. It can cause serious nutritional complications.
Bowel Obstruction
Reports of ileus (temporary bowel paralysis) and bowel obstruction have emerged in patients using GLP-1 medications. These can be life-threatening without prompt treatment.
Vision Loss
Emerging research has associated GLP-1 receptor agonists with non-arteritic anterior ischemic optic neuropathy (NAION), a serious condition that can cause irreversible vision loss.
Severe GI Symptoms
Beyond gastroparesis, some patients report severe nausea, vomiting, diarrhea, and abdominal pain that required hospitalization or led to significant weight loss and malnutrition.
Other Serious Effects
Pancreatitis, kidney injury, and other serious complications have also been reported. If you experienced a serious adverse event after taking a GLP-1 medication, you may qualify.
Ozempic Lawsuit FAQ
Common questions about Ozempic injury claims in Canada.
Serious side effects associated with Ozempic include gastroparesis (delayed gastric emptying / stomach paralysis), bowel obstruction, severe nausea and vomiting requiring hospitalization, and reports of vision loss (non-arteritic ischemic optic neuropathy). If you experienced any serious side effect after taking Ozempic, you may have grounds for a legal claim.
Health Canada has issued communications regarding GLP-1 medications and their association with gastroparesis and ileus. The product monograph for Ozempic has been updated to reflect emerging safety information. Regulatory communications from Health Canada are separate from legal proceedings and do not determine whether you qualify for a claim.
Ozempic lawsuits in Canada are civil legal claims brought by individuals who allege they suffered serious injuries after using Ozempic and that Novo Nordisk (the manufacturer) failed to adequately warn prescribers and patients of the risks. Legal proceedings are ongoing and individual circumstances vary significantly.
Yes. Ozempic was originally approved for type 2 diabetes management. If you took Ozempic for any reason and experienced a serious side effect, your intended use of the medication does not prevent you from potentially having a qualifying claim.
Ready to Find Out If You Qualify?
The Ozempic case review process is free, confidential, and carries no obligation. If you believe Ozempic caused your injury, get started now.
- You took Ozempic, Wegovy, or another GLP-1 medication
- You experienced a serious side effect
- You are a resident of Canada
- You have not yet retained a lawyer for this matter
Free case review · No obligation · No upfront fees
Important Legal Notice
GLP-1 Justice is not a law firm and does not provide legal advice. Submitting information through this site does not create an attorney–client relationship. Information submitted may be shared with licensed legal service providers for case review.
The information on this website is provided for general informational purposes only and does not constitute legal advice. No lawyer–client relationship is formed by submitting information through this site or by calling any phone number listed herein.
Individual results vary. Past outcomes are not indicative of future results. Qualifying for a case review does not guarantee a legal claim exists or will succeed. All legal claims are subject to applicable limitation periods and other legal requirements.
This site is intended for residents of Canada only. Services may not be available in all provinces or territories.